Used in biomedical research to quantify BCL-2 protein levels in cell or tissue samples, this ELISA kit helps study apoptosis regulation. It is widely applied in cancer research to evaluate the expression of anti-apoptotic proteins and assess the impact of therapeutic agents on cell survival pathways. Researchers also use it in toxicology studies to determine cellular responses to stress or drug exposure. The kit enables high-throughput screening in drug development and supports investigations into autoimmune diseases, neurodegenerative disorders, and other conditions linked to dysregulated apoptosis.